Experiment 626300
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | WYATT,KM: DIMMOCK,PW: JONES,PW: O'BRIEN,PMS:. (1999). EFFICACY OF VITAMIN B-6 IN THE TREATMENT OF PREMENSTRUAL SYNDROME: SYSTEMATIC REVIEW.. 318(7195) |
| Amount utilized | |
| Compound isolated | |
| Disease | SYSTEMATIC REVIEW OF PUBLISHED AND UNPUBLISHED RANDOMISED PLACEBO CONTROLLED TRIALS OF THE EFFECTIVENESS OF VITAMIN B-6 IN THE MANAGEMENT OF PREMENSTRUAL SYNDROME. THE PUBLISHED TRIALS REPRESENTING 940 PATIENTS WITH PREMENSTRUAL SYNDRONE. OUTCOME MEASURED PROPORTION OF WOMEN WHOSE OVERALL PREMENSTRUAL SMYPTOMS SHOWED AN IMPROVEMENT OVER PLACEBO. A SECONDARY ANALYSIS WAS PERFORMED ON THE PROPORTION OF WOMEN WHOSE PREMENSTRUAL DEPRESSIVE SYMPTOMS SHOWED AN IMPROVEMENT OVER PLACEBO. RESULTS. ODDS RATIO RELATIVE TO PLACEBO FOR AN IMPROVEMENT IN OVERALL PREMENSTRUAL SYMPTOMS WAS 2.32 (95% CONFIDENCE INTERVAL 1.95 TO 2.54) ODDS RATIO RELATIVE TO PLACEBO FOR AN IMPROVEMENT IN DEPRESSIVE SYMPTOMS WAS 1.69 (1.39 TO 2.06) FROM FOUR TRIALS REPRESENTING 541 PATIENTS. CONCLUSION. CONCLUSIONS ARE LIMITED BY THE LOW QUALITY OF MOST OF THE TRIALS INCLUDED. RESULTS SUGGEST THAT DOSES OF VITAMIN B-6 UP TO 100 MG/DAY ARE LIKELY TO BE OF BENEFIT IN TREATING PREMENSTRUAL SYMPTOMS AND PREMENSTRUAL DEPRESSION. |
| Dose amount | 100.0 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | FEMALE |